Cargando…

Current Approaches for Personalized Therapy of Soft Tissue Sarcomas

Soft tissue sarcomas (STS) are a highly heterogeneous group of cancers of mesenchymal origin with diverse morphologies and clinical behaviors. While surgical resection is the standard treatment for primary STS, advanced and metastatic STS patients are not eligible for surgery. Systemic treatments, i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kirsanov, Kirill I., Lesovaya, Ekaterina A., Fetisov, Timur I., Bokhyan, Beniamin Yu, Belitsky, Gennady A., Yakubovskaya, Marianna G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152984/ https://www.ncbi.nlm.nih.gov/pubmed/32317857 http://dx.doi.org/10.1155/2020/6716742

Ejemplares similares

Perspectives of Cell Sensitivity/Resistance Assay in Soft Tissue Sarcomas Chemotherapy
por: Fetisov, Timur I., et al.
Publicado: (2023)

Soft Tissue Sarcoma Study: Association of Genetic Alterations in the Apoptosis Pathways with Chemoresistance to Doxorubicin
por: Kirilin, Evgeny M., et al.
Publicado: (2022)

Analysis of Multiple Drug Resistance Mechanism in Different Types of Soft Tissue Sarcomas: Assessment of the Expression of ABC-Transporters, MVP, YB-1, and Analysis of Their Correlation with Chemosensitivity of Cancer Cells
por: Moiseeva, Natalia I., et al.
Publicado: (2022)

Prevention of therapy-related malignances in cancer survivors
por: Belitsky, Gennady A., et al.
Publicado: (2019)

Effects of G-Quadruplex-Binding Plant Secondary Metabolites on c-MYC Expression
por: Zenkov, Roman G., et al.
Publicado: (2022)

Toxicological Properties of 7-Methylguanine, and Preliminary Data on its Anticancer Activity
por: Kirsanov, Kirill, et al.
Publicado: (2022)

A Brief Overview of the Paradoxical Role of Glucocorticoids in Breast Cancer
por: Zhidkova, Ekaterina M, et al.
Publicado: (2020)

Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo
por: Fetisov, Timur I., et al.
Publicado: (2023)

Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269
por: Zenkov, Roman G., et al.
Publicado: (2021)

HeLa TI cell-based assay as a new approach to screen for chemicals able to reactivate the expression of epigenetically silenced genes
por: Maksimova, Varvara, et al.
Publicado: (2021)

Nutritional Sensor REDD1 in Cancer and Inflammation: Friend or Foe?
por: Zhidkova, Ekaterina M., et al.
Publicado: (2022)

Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats
por: Lesovaya, Ekaterina A., et al.
Publicado: (2015)

The long winding road to the safer glucocorticoid receptor (GR) targeting therapies
por: Lesovaya, Ekaterina A., et al.
Publicado: (2022)

Minor grove binding ligands disrupt PARP-1 activation pathways
por: Kirsanov, Kirill I., et al.
Publicado: (2014)

Insights into the Mechanism of Curaxin CBL0137 Epigenetic Activity: The Induction of DNA Demethylation and the Suppression of BET Family Proteins
por: Maksimova, Varvara, et al.
Publicado: (2023)

REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids
por: Baida, Gleb, et al.
Publicado: (2015)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

Prediction tools for the personalized management of soft-tissue sarcomas of the extremity
por: Acem, Ibtissam, et al.
Publicado: (2022)

FACT is a sensor of DNA torsional stress in eukaryotic cells
por: Safina, Alfiya, et al.
Publicado: (2017)

Adjuvant Chemotherapy of Soft Tissue Sarcoma—Current Status
por: Judson, Ian
Publicado: (2000)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Olaratumab’s failure in soft tissue sarcoma
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

The Molecular Biology of Soft-Tissue Sarcomas and Current Trends in Therapy
por: Quesada, Jorge, et al.
Publicado: (2012)

Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
por: Gordon, Erlinda M., et al.
Publicado: (2016)

Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas
por: Nakano, Kenji, et al.
Publicado: (2018)

Current Status and Future Directions of Immunotherapies in Soft Tissue Sarcomas
por: Kerrison, William G. J., et al.
Publicado: (2022)

Type III collagen metabolism in soft tissue sarcomas.
por: Wiklund, T. A., et al.
Publicado: (1992)

The Molecular Biology of Soft Tissue Sarcomas: Current Knowledge and Future Perspectives
por: Vibert, Julien, et al.
Publicado: (2022)

Retroperitoneal soft tissue sarcoma
por: Zepeda, Ernesto, et al.
Publicado: (2007)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

Soft Tissue Sarcomas of the Kidney
por: Köhle, Olivia, et al.
Publicado: (2015)

Bone and Soft Tissue Sarcoma
por: Ruggiero, Antonio
Publicado: (2020)

Trabectedin for soft tissue sarcoma
Publicado: (2021)

Studies of an alveolar soft tissue sarcoma.
por: Udekwu, F. A., et al.
Publicado: (1965)

Mediastinal soft tissue sarcoma: dark sides and future lights
por: Palmieri, Giovannella, et al.
Publicado: (2020)

Delays in Referral of Soft Tissue Sarcomas
por: Johnson, G. D., et al.
Publicado: (2008)

The proteomic landscape of soft tissue sarcomas
por: Burns, Jessica, et al.
Publicado: (2023)

Multidisciplinary Management of Soft Tissue Sarcoma
por: Nystrom, Lukas M., et al.
Publicado: (2013)

Telomere maintenance in soft tissue sarcomas
por: Eastley, Nicholas, et al.
Publicado: (2017)

Paediatric bone and soft tissue sarcoma
por: Anderson, J
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_jbmb1q6nicanuafivjirjishsd